X-150469875-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_005491.5(MAMLD1):c.302C>T(p.Pro101Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000669 in 1,210,059 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005491.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 111891Hom.: 0 Cov.: 23 AF XY: 0.0000294 AC XY: 1AN XY: 34057
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183412Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67858
GnomAD4 exome AF: 0.0000701 AC: 77AN: 1098168Hom.: 0 Cov.: 33 AF XY: 0.0000550 AC XY: 20AN XY: 363526
GnomAD4 genome AF: 0.0000357 AC: 4AN: 111891Hom.: 0 Cov.: 23 AF XY: 0.0000294 AC XY: 1AN XY: 34057
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.302C>T (p.P101L) alteration is located in exon 3 (coding exon 3) of the MAMLD1 gene. This alteration results from a C to T substitution at nucleotide position 302, causing the proline (P) at amino acid position 101 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 14, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at